The use of epidural fentanyl by patient-controlled analgesia (PCA) may be a useful method of providing high-quality postoperative analgesia on the general surgical ward. The successful use of this technique requires an infusion pump with specific characteristics. Three Provider 5500, newly-developed, batterypowered PCA pumps, were tested to determine their accuracy, threshold of occlusion alarm limits and stored volume characteristics. These measurements were repeated following the in-line addition of an 18 gauge epidural catheter and two 0.2 micron filters. Pumps delivered on average within 3% of stated infusion rates and within 3% of bolus dose size. Occlusion pressures generated were between 1200 and 1360 mmHg, while the mean stored volume was 0.12 ml. Accuracy of delivery was maintained at lower voltage inputs. Addition of the catheter failed to alter the accuracy of the pumps tested. Siphoning of fluid was possible on disconnection of cartridge from pump. This problem did not occur with the addition of an epidural catheter and filter. This device has features which make it suitable for the safe delivery of epidural PCA. Care, however, needs to be taken on changing cartridges to prevent accidental administration of a drug bolus to the patient.
Intravenous patient-controlled analgesia (PCA) is recognised as being an effective method of providing postoperative analgesia. 1 Its utility stems from the ability of the technique to match the wide variations in opioid requirements between patients. Epidural opioids can produce excellent analgesia with the advantage of a lower opioid dose. 2 Use of this technique has been limited by reports of late respiratory depression which is particularly associated with the hydrophilic opioids such as morphine. Epidural infusion of fentanyl, with or without small bolus doses, has not been associated with this adverse effect. Dose requirements of epidural fentanyl vary between patients, and although this may be less marked than when using the intravenous route, the use of fentanyl by epidural PCA (PCEA) would seem to be a logical choice, combining the advantage of individual dose titration with lower opioid doses by use of the epidural route.
Practical experience with PCEA has shown that infusion pumps used for administration of epidural drugs require particular characteristics. These include portability, accuracy of infusion against a back pressure and the ability to deliver a bolus dose without activation of the occlusion alarm while retaining the ability to detect an occlusion. There are several infusion and PCA pumps on the market, and so far as we are aware, none claims to be suitable for epidural administration. In our institution we have found limitations in two currently available pumps; the Terumo syringe driver and the Graseby PCAS. When Terumo syringe drivers (Model STC-521, Terumo Corporation, Tokyo) were used for continuous epidural infusions plus nurse-administered supplementary doses, the high hydrostatic pressures needed to deliver a bolus through the catheter and filter activated the occlusion alarm. Using epidural PCA with the Graseby PCAS (Graseby PCAS, Graseby Medical, Watford, Herts, U.K.), we again found that high infusion rates frequently activated the high pressure occlusion alarms. Furthermore, as both devices were bulky, pole-mounted, mains-operated pumps, this tended to hinder the mobilisation of the patients despite their good analgesia. The importance of not resistricting pa.tients' mobility with cumbersome peA devices has been commented on in recent review of epidural analgesia. 3 The Provider 5500 (Pancretec Inc., San Diego, USA) is a new, portable, battery-operated peA pump. The aim of this study was to assess its suitability for epidural peA.
DESCRIPTION OF EQUIPMENT
Three Provider 5500 pumps were obtained from Abbott Australasia for testing. Each pump was subjected to an electrical safety test based on Australian Standard AS-3551 1988 (Standards Association of Australia, Acceptance Testing and In-service Testing-Electromedical Equipment).
The Provider 5500 pump is a lightweight (400 g), compact (132 mm by 86 mm by 33 mm) microcomputer-controlled eccentric-rotor peristaltic pump ( Figure 1 ). It consists of a control panel of recessed membrane switches, a display which is selectively illuminated during use, and a drive motor. The pump is powered by two 9 V lithium batteries in parallel configuration. The battery life expectancy is thirty days when set at a continuous infusion rate of less than 20 ml.hr -I while at rates of greater than 20 ml.hr -I the volume infused is limited to less than 4,800 ml. In use, when the batteries are approaching low voltages, an intermittent alarm sounds, indicating the need for immediate replacement. If the pump operation is allowed to continue, a continuous alarm sounds and the pump stops, thereby preventing potentially inaccurate infusion rates at low operating voltage levels. The pump can maintain memory protection for the operating program for five minutes without battery support. Delivery rates can range from 0.1 ml.hr-I to 250 ml.hr-I; programmable volumes 3000 ml down to 0.1 ml. Lockout times can be set between 1 minute to 200 hours. The pump can be programmed in milligrams (range 0.1 mg.ml-I to 1000 mg.ml-I ) or in millilitres per hour.
A dedicated infusion set is required for the Provider 5500, consisting of a bag spike, pump housing, two side clamps and male Luer connector. A colour coding system on the cartridge assists set-up along with design features incorporated in the pump that prevent incorrect placement of the cartridge. Alarms, both audible and visual, are present to indicate the following; line check, latch open, occlusion or cartridge improperly positioned; air in-line; low reservoir; low battery; end of infusion; overuse of prime; system problem and computer error. The reservoir is attached to the cartridge and can be any standard intravenous fluid container. Increased patient mobility can be achieved by the incorporation of the pump and fluid container (limited to 250 ml) into a lockable soft plastic carrying case with shoulder strap for use with an ambulatory patient. If security of pump and drug is required, then a lockable, polemounted, transparent rigid 'lockbox' is available.
METHODS

Accuracy
Flow rates were determined by recording the weight of saline 0.9% delivered by the pump over a set period of time using a calibrated balance weighing to 0.01 g. (Mettler 2000, Mettler Instrument, AG Zurich, Switzerland). Readings were made every minute for sixty minutes. Accuracy of delivery was measured over a range of flow rates likely to be used in clinical practice, namely flow rates of 1, 5, 10 and 20 ml.hr-I in continuous delivery. Accuracy of bolus dose delivery was also measured for bolus doses of 1, 5, 10 and 20 ml, the measurement being carried out ten times at each volume. In order to assess the accuracy of this pump under the conditions under which it was to be used, all measurements were repeated with the pumps infusing through a resistance consisting of two 0.2 micron filters (Aerodisc, Gelman Sciences, Daw Park, South Australia) and an 18 gauge epidural catheter (Portex Ltd, Hythe, Kent, England), this being the configuration used in this hospital. The effect of mobilisation and movement was assessed by attaching a pump along with a collecting system to one of the investigators (M.K.). The collecting system consisted of a closed preweighed container with a small orifice in its lid. Infusion rates of 1, 5, 10 and 20 ml.hc 1 were commenced and the subject performed normal daily activities. At least twenty minutes each hour were spent walking. This was repeated three times at each infusion rate. The amount infused after sixty minutes was accurately weighed as above.
Accuracy of infusion rates at variable voltage inputs
The terminals of the three pumps were attached to an adjustable D.e. voltage supply. The voltage was reduced and the values noted when visual and audible alarms appeared, indicating a low battery state, along with the voltage associated with complete failure of the system. Once these voltages were noted, an infusion rate of 10 ml.hr -1 was set at these values to assess the accuracy of infusion rates at low battery power. These were measured using a Dynatec Model 404A Infusion Device Analyser (Dynatec, Carson City, Nevada U.S.A.), precalibrated to an accuracy of 1 % Occlusion pressure Occlusion pressure was measured by allowing the pump to infuse against a closed stopcock and measuring the in-line pressure with an aneroid gauge which had been calibrated against a mercury manometer. The pressure at which the occlusion alarm was activated was noted for each of the three pumps.
Stored volume
Stored volume was measured by operating the pump against a closed stopcock until the occlusion alarm sounded. The stopcock was attached to the distal end of the delivery tubing and consisted ofa rigid noncompliant plastic two-way tap. The pump Pump was then stopped, the stopcock opened, and the volume of expelled fluid measured by weighing. This measurement was repeated five times on each of the three pumps.
Siphoning effect
The administration set along with cartridge was removed from the pump. This was attached to an 18 gauge epidural catheter along with two 0.2 micron bacterial filters. The eccentric wheel was rotated to allow free flow of fluid. The reservoir of saline was then placed at three different heights; 100 cm, 50 cm and 25 cm above a preweighed beaker on an electronic balance. The weight of saline expelled during sixty seconds was determined. This was repeated three times at each height. The effect on the flow rate without the epidural configuration was also determined.
RESULTS
The three Provider 5500 pumps all passed the electrical safety test.
Accuracy
In continuous delivery over a range of flow rates from 1-20 ml.hr -1, the volume delivered was never in error by more than 3% of the nominal value. This accuracy was maintained when infusing against a resistance (Table 1) . Bolus doses ranging from 1.0 to 20 ml were on average never in error by more than 3%. When delivering bolus doses against a resistance the average error was always less than 3% ( Table 2) . When a pump was tested during mobilisation, accuracy was within 5% of preset infusion rates.
Accuracy of infusion rates at variable voltage inputs.
The nominal operating voltage is 9 V. The '10 batt' visual indicator appeared consistently at 6.9 V for all three pumps. The intermittent alarm was only activated when the pump next infuses a bolus or continues with an incremental infusion. The persistent audible alarm sounded at 5.9 V while the screen cleared and pump stopped working at 5.3 V. Infusion rates at 10 ml.hr -1 were measured at 9 V (normal), 6.9 V (low battery waming) and 5.5 V (i.e. the voltage just above the value noted which caused the screen and pump to fail). The volumes delivered were within 1.0% of preset values.
Occlusion pressure
The occlusion pressure alarm on the three pumps was found to be set at 1200, 1260 and 1360 mmHg.
Stored volumes
The mean stored volume within the drug administration system was 0.12 rnl with a standard deviation of 0.02 rnl.
Siphoning effect
The presence of the epidural catheter along with the bacterial filters prevented free fluid flow at all heights tested. However, free flow was possible at all three heights when the epidural configuration was removed. Mean flow rates delivered at 100 cm, 50 cm and 25 cm were 26.1 ml.min -1 (25.5-26.8), 14.5 rnl.min -1 (14.2-15.1) and 9.9 rnl.min -1 (9.6-10.3) respectively.
DISCUSSION
The need for a safe and compact device for PCEA was implied in a recent review of epidural analgesia. 2 The Provider 5500 PCA pumps tested were found to deliver accurately in both continuous infusion and bolus (PCA) modes over a range of flow rates likely to be used in clinical practice. The accuracy was well within the 10% limit recommended for infusion pumps in general use, 4 This accuracy was maintained even when infusing against a resistance which may be encountered in clinical use, Movement and ambulation also had no detrimental effect on accuracy of delivered infusions. This is essential for a pump that is designed to promote increased patient mobility. It is of paramount importance when using battery-powered pumps, that the delivery characteristics are not altered by variable voltage outputs as the battery discharges. The Provider 5500 operates accurately and safely as the batteries run down, so that at voltages when the low-battery alarm sounds or just before the pump ceases operating, accurate administration is maintained. Batteries placed in parallel allow for better performance. However, this also predisposes the batteries to self-discharge if left connected within the pump when not in use. It is important therefore that these are removed once the pump is no longer required.
High hydrostatic pressures are required to infuse through the resistance of an epidural catheter and filter system. The pressure generated depends on the resistance to fluid flow of the system and on the flow rate. Problems with activation of the occlusion alarm are therefore likely to occur during administration of a bolus dose by a pump with a low occlusion alarm pressure. The Provider 5500 delivers a bolus dose rapidly at 250 rnl.hr -1 but has sufficiently high occlusion alarm pressure to avoid activation of the alarm. This makes it suitable for epidural use, but could produce the problem of delayed detection of an occluded catheter or cannula, which may result in poor quality analgesia or a dangerous accidental bolus dose (see below). The dedicated giving set has a low volume and low compliance, so that pressure will rise rapidly and activate the alarm in the event of an occlusion. These characteristics of the giving set also result in a low stored volume. s This is the volume of fluid which collects behind an occlusion and which can be released as an accidental dose when the occlusion is cleared. The ECRI recommendations suggest that the stored volume should be less than three times the minimum bolus dose. Although this pump can be programmed to provide a very small bolus dose volume of 0.1 ml, it still complies with these recommendations, with a stored volume of 0.12 ml. The potential for free flow when the cartridge is removed from the pump needs emphasis to all who use the pump. Inadvertent failure to close the line with the gate clips provided may lead to accidental drug infusion.
Despite recognition of the advantages of administering opioids by the epidural route, this effective means of providing analgesia has been limited to intensive care and high-dependency areas by reports of late and unpredictable respiratory depression. These reports have mostly been associated with the use of morphine. Estimates of the incidence of late respiratory depression when using extradural morphine range from 0.09%-0.90%6. Late respiratory depression in association with the use of morphine is probably related to its hydrophilic nature, which allows morphine to be present in the CSF and therefore to be available for cephalad spread with the potential for causing respiratory depression on arrival at the brainstem. Theoretically the lipophilic properties of fentanyl should make it is less prone to producing this side-effect. To date there have been no reports of respiratory depression following epidural fentanyl infusions or small bolus doses, although delayed respiratory depression has been reported after a relatively large bolus dose of 100 mcg. 7 • 8 The use of patient-controlled analgesia by the epidural route has been described by a number of workers,2 and our interest in identifying a suitable PCEA device stems from a study we are conducting to investigate the safety and effectiveness of the technique. Infusion pumps have generally been designed for delivery of intravenous drugs, and are not necessarily suited to the particular requirements of delivering through an epidural system. The availability of an infusion pump which can accommodate these particular requirements is vital to the successful use of this technique. We found the Provider 5500 to be well suited to this use, being a portable, compact, lightweight infusion pump, which delivers accurately in continuous and bolus modes, even being unaffected by movement. Similarly the high resistance offered by the epidural catheter set and at low voltage output states failed to alter its accuracy. It also has a sufficiently high occlusion alarm pressure, and an appropriately small stored volume, all features which will make it a very suitable pump for PCEA. Care, however, needs to be exercised when disconnecting the cartrige from the pump, as siphoning of analgesia solution may be possible when used in the intravenous mode.
